# Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients

> **NCT01781871** · PHASE4 · COMPLETED · sponsor: **Helsinki University Central Hospital** · enrollment: 182 (actual)

## Conditions studied

- Kidney Transplantation
- Liver Transplantation

## Interventions

- **BIOLOGICAL:** Prevenar13
- **BIOLOGICAL:** Pneumovax

## Key facts

- **NCT ID:** NCT01781871
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2017-10-04
- **Final completion:** 2017-10-04
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2017-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01781871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01781871, "Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01781871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*